Black Market Follistatin-344 Products Detected, Posing Significant Health and Doping Risks

Follistatin-344 is a potent myostatin inhibitor, a protein that naturally limits muscle growth. Due to its potential to enhance muscle mass, Follistatin-344 has become a target for misuse in sports and bodybuilding, leading to its emergence on the black market. The unregulated nature of these illicit products raises serious concerns regarding their purity, dosage accuracy, and potential contamination, posing substantial health risks to users. This study aimed to develop and apply robust analytical methodologies to accurately detect and characterize black market Follistatin-344 preparations, addressing the critical knowledge gap regarding their composition and authenticity.

The study successfully confirmed the presence of Follistatin-344 in all analyzed black market samples, unequivocally demonstrating its availability in illicit supply chains. However, the analytical results revealed a concerning pattern of substandard quality and adulteration. Specifically, over 70% of the samples contained significant impurities, including truncated peptide fragments, oxidation products, and non-peptide contaminants. The most critical finding was that nearly 40% of the black market Follistatin-344 products contained less than 50% of the declared active ingredient, with some samples showing as little as 15% purity when compared to pharmaceutical-grade reference standards. Furthermore, several samples were found to be co-formulated with undeclared substances, such as other anabolic agents or excipients not typically used in sterile injectable preparations. The developed HR-LC-MS methods proved highly effective, demonstrating detection limits in the low nanogram range, ensuring reliable identification even in highly diluted or impure samples.